Latest Cancer treatments Stories
DALLAS, January 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance
MediVet Biologic’s collaboration with researchers at the University of Kentucky’s College of Medicine has led to a groundbreaking novel animal biologic, K9-ACV: an Autologous Cancer Vaccine
Findings Published in Journal of Community and Supportive Oncology Are First to Show Improvement in Emotional Well-Being and Quality of Life NEW YORK, Jan.
GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, market size and demand forecasts on the global Radiation Therapy Equipment market.
Industry veteran brings nearly 20 years of pharmaceutical development and licensing experience to the company FREDERICK, Md., Jan.
Company expands lung cancer clinical program for its Precision Cancer MonitoringSM solution to up to 700 patients at three leading cancer centers SAN DIEGO, Jan.
- Results from two large trials individually showed an improvement in the secondary endpoint of overall survival for patients with the most common EGFR mutation (Del19) RIDGEFIELD, Conn., Jan.
Company continues to expand its clinical collaborations with National Comprehensive Cancer Network centers across a broad range of clinically actionable mutations in major cancer types
- A political dynamiter.
More Images (3 images) »